Malta will soon become cannabis medicine producer
The proposed law will permit the industrial production of cannabis products for medical use, opening up a new economic sector.
Cannabis May Protect Alcohol Users From Liver Disease
They wanted to see if the observed anti-inflammatory effects of cannabis also affect the development of liver disease. The study was led by Adeyinka Charles Adejumo of North Shore Medical Center in Salem, Massachusetts
Researchers analyzed more than a dozen studies on how marijuana affects your heart
The findings sounded alarming. But like any study, this one had key limitations, including the fact that it defined cannabis “users” as anyone who’d ever tried the drug. More importantly, however, it highlighted an important gap in our current understanding of the science of cannabis:
House Panel Backs Expansion Of Medical Marijuana Oils
Advocates for medical marijuana have tried and failed in Virginia year after year. A few years ago, they persuaded lawmakers to allow it for epilepsy.
Canada’s Aurora Cannabis to buy rival to create world’s most valuable weed firm
“The action is where the medical cannabis export markets are, which are much larger than Canada,” said Chris Damas, editor of the BCMI Cannabis Report. “CanniMed has patents, they have relationships with different universities, research and clinical trials, and export relations with other countries, and Aurora wants to add to their own relationships in Europe.”
Pharmaceutical cannabis could reduce sudden falls for people with treatment-resistant epilepsy
The trial reduced the frequency of seizures in patients with the illness, just 10% of whom had previously been found to respond to conventional drug treatments, though the authors say that efficacy and safety of the new treatment ‘now needs to be confirmed’.
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells
Clostridium difficile toxin A is responsible for colonic damage observed in infected patients. Drugs able to restore Clostridium difficile toxin A-induced toxicity have the potential to improve the recovery of infected patients. Cannabidiol is a non-psychotropic component of Cannabis sativa, which has been demonstrated to protect enterocytes against chemical and/or inflammatory damage and to restore intestinal mucosa integrity. Cannabidiol improved Clostridium difficile toxin A-induced damage in Caco-2 cells, by inhibiting the apoptotic process and restoring the intestinal barrier integrity, through the involvement of the CB1 receptor.
Queensland trial evaluating benefits of medical cannabis for cancer patients
The Federal Government will invest the money in world-leading medical researchers to target devastating and rare conditions like acute lymphoblastic leukaemia in infants, aplastic anaemia, multiple sclerosis and Huntington’s disease.
We want branches across the country’ – Teesside Cannabis Club welcomes crime commissioner
Mr Jones joins Jeremy Kyle and Durham’s Police, Crime and Victims Commissioner Ron Hogg as the latest in a line of public figures who have asked club members to share their experiences as they consider the debate around marijuana use, which is now legal in a number of countries.
Synthetic medical marijuana could fuel Singapore’s future economy and create jobs
Amid the harsh sentences meted out to those who abuse cannabis, scientists at the National Research Foundation (NRF) are working to access the medicinal potential of the chemical compounds found in cannabis – cannabinoids – without negative side effects.